142 related articles for article (PubMed ID: 32551221)
1. Opioid antidote induced pulmonary edema and lung injury.
Yarlagadda K; Kim J; Kanderi T; Sendil S; Nookala VK
Respir Med Case Rep; 2020; 30():101107. PubMed ID: 32551221
[TBL] [Abstract][Full Text] [Related]
2. Do heroin overdose patients require observation after receiving naloxone?
Willman MW; Liss DB; Schwarz ES; Mullins ME
Clin Toxicol (Phila); 2017 Feb; 55(2):81-87. PubMed ID: 27849133
[TBL] [Abstract][Full Text] [Related]
3. Naloxone-associated pulmonary edema following recreational opioid overdose.
Kummer RL; Kempainen RR; Olives TD; Leatherman JW; Prekker ME
Am J Emerg Med; 2022 Mar; 53():41-43. PubMed ID: 34973491
[TBL] [Abstract][Full Text] [Related]
4. Out-of-hospital treatment of opioid overdoses in an urban setting.
Sporer KA; Firestone J; Isaacs SM
Acad Emerg Med; 1996 Jul; 3(7):660-7. PubMed ID: 8816181
[TBL] [Abstract][Full Text] [Related]
5. Naloxone-associated pulmonary edema in a 3-year-old with opioid overdose.
Grout S; Dave M; Lefort R
J Am Coll Emerg Physicians Open; 2022 Jun; 3(3):e12740. PubMed ID: 35619624
[TBL] [Abstract][Full Text] [Related]
6. Preventing deaths from rising opioid overdose in the US - the promise of naloxone antidote in community-based naloxone take-home programs.
Straus MM; Ghitza UE; Tai B
Subst Abuse Rehabil; 2013 Sep; 2013(4):65-72. PubMed ID: 24273417
[TBL] [Abstract][Full Text] [Related]
7. From Friend to Foe: A Case of Naloxone-Induced Pulmonary Edema.
Ghalayni R; Al Kalaji B; Malik K
Hosp Pharm; 2024 Aug; 59(4):407-410. PubMed ID: 38919766
[TBL] [Abstract][Full Text] [Related]
8. American College of Medical Toxicology and the American Academy of Clinical Toxicology position statement: nalmefene should not replace naloxone as the primary opioid antidote at this time.
Stolbach AI; Mazer-Amirshahi ME; Nelson LS; Cole JB
Clin Toxicol (Phila); 2023 Nov; 61(11):952-955. PubMed ID: 38039052
[TBL] [Abstract][Full Text] [Related]
9. Characterizing and combating the opioid epidemic in the Los Angeles County jail system.
Tran NT; Muradian IK; Qureshi N; Singh J; Henderson SO
J Subst Use Addict Treat; 2023 Apr; 147():208984. PubMed ID: 36841073
[TBL] [Abstract][Full Text] [Related]
10. A Complicated Opioid Overdose: A Simulation for Emergency Medicine Residents.
Keenan MP; Schenker KA; Sarsfield MJ
MedEdPORTAL; 2017 Aug; 13():10616. PubMed ID: 30800818
[TBL] [Abstract][Full Text] [Related]
11. A study protocol for a European, mixed methods, prospective, cohort study of the effectiveness of naloxone administration by community members, in reversing opioid overdose: NalPORS.
Metrebian N; Carter B; Eide D; McDonald R; Neale J; Parkin S; Dascal T; Mackie C; Day E; Guterstam J; Horsburgh K; Kåberg M; Kelleher M; Smith J; Thiesen H; Strang J
BMC Public Health; 2023 Aug; 23(1):1608. PubMed ID: 37612698
[TBL] [Abstract][Full Text] [Related]
12. Is early discharge safe after naloxone reversal of presumed opioid overdose?
Etherington J; Christenson J; Innes G; Grafstein E; Pennington S; Spinelli JJ; Gao M; Lahiffe B; Wanger K; Fernandes C
CJEM; 2000 Jul; 2(3):156-62. PubMed ID: 17621393
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary Complications of Opioid Overdose Treated With Naloxone.
Farkas A; Lynch MJ; Westover R; Giles J; Siripong N; Nalatwad A; Pizon AF; Martin-Gill C
Ann Emerg Med; 2020 Jan; 75(1):39-48. PubMed ID: 31182316
[TBL] [Abstract][Full Text] [Related]
14. The Opioid Overdose Resuscitation Education for Addiction Counselors and Trainees (Opioid Overdose REACT) naloxone response education pilot project improved confidence and knowledge among addiction counselors and trainees.
Argenyi MS; Evans JK; Gay Y; Epstein DH; Weiss ST
Clin Toxicol (Phila); 2023 Jul; 61(7):509-517. PubMed ID: 37427894
[TBL] [Abstract][Full Text] [Related]
15. Neighborhood-Level and Spatial Characteristics Associated with Lay Naloxone Reversal Events and Opioid Overdose Deaths.
Rowe C; Santos GM; Vittinghoff E; Wheeler E; Davidson P; Coffin PO
J Urban Health; 2016 Feb; 93(1):117-30. PubMed ID: 26800987
[TBL] [Abstract][Full Text] [Related]
16. Optimizing naloxone distribution to prevent opioid overdose fatalities: results from piloting the Systems Analysis and Improvement Approach within syringe service programs.
Patel SV; Wenger LD; Kral AH; Sherr K; Wagner AD; Davidson PJ; Lambdin BH
BMC Health Serv Res; 2023 Mar; 23(1):278. PubMed ID: 36949494
[TBL] [Abstract][Full Text] [Related]
17. Intranasal naloxone administration for treatment of opioid overdose.
Robinson A; Wermeling DP
Am J Health Syst Pharm; 2014 Dec; 71(24):2129-35. PubMed ID: 25465584
[TBL] [Abstract][Full Text] [Related]
18. Death matters: understanding heroin/opiate overdose risk and testing potential to prevent deaths.
Strang J
Addiction; 2015 Jul; 110 Suppl 2():27-35. PubMed ID: 26042565
[TBL] [Abstract][Full Text] [Related]
19. Impact of a publicly funded pharmacy-dispensed naloxone program on fatal opioid overdose rates: A population-based study.
Antoniou T; Men S; Tadrous M; Leece P; Munro C; Gomes T
Drug Alcohol Depend; 2022 Jul; 236():109473. PubMed ID: 35523113
[TBL] [Abstract][Full Text] [Related]
20. Review of naloxone safety for opioid overdose: practical considerations for new technology and expanded public access.
Wermeling DP
Ther Adv Drug Saf; 2015 Feb; 6(1):20-31. PubMed ID: 25642320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
